Real-world data enables to test hypotheses is advance of clinical trials.
For researchers, well-characterized human samples are valuable commodities. And that’s exactly what Novaseek Research delivers to its customers Novaseek’s CEO Kate Torchilin told Clinical Informatics News last month at a meeting in Boston. “Having the biospecimen is very important here,” she said. “You can only deduce so much from data.”
We are in an exciting time with many innovative companies that are improving parts of the process all the way from development to clinical care, all aimed toward improving the lives of patients.
Novaseek is pursuing CROs and pharmas to employ its clinical data platform, Clinical Data
Network for Research (CDNR), said CEO Kate Torchilin in an interview with this news service
at the Biotech Showcase conference in San Francisco.
PharmaVoice 2017: “All of us in life sciences and healthcare are privileged to be working in an industry that is constantly evolving and re-inventing itself to better serve patients and help them live healthier lives. Of course, the patient is always the central theme of everything that we do; however, as we move into 2017, there is a strong focus to put the real-world patient front and center in the R&D process, expanding patient interaction beyond the controlled clinical trial setting.”